We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+8.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$518B
AUM Growth
+$24.3B
Cap. Flow
-$1.52B
Cap. Flow %
-0.29%
Top 10 Hldgs %
29.53%
Holding
15,731
New
1,614
Increased
6,434
Reduced
5,866
Closed
1,611

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$555M
2
C icon
Citigroup
C
+$407M
3
MDT icon
Medtronic
MDT
+$401M
4
CMG icon
Chipotle Mexican Grill
CMG
+$392M
5
GILD icon
Gilead Sciences
GILD
+$362M

Sector Composition

Rank Sector Weight
1 Technology 3.02%
2 Healthcare 2.92%
3 Consumer Discretionary 2.17%
4 Financials 2.1%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GIPR icon
14501
Generation Income Properties
GIPR
$727K
-2,305
Closed -$93.8K
GJAN icon
14502
FT Vest US Equity Moderate Buffer ETF January
GJAN
$439M
-8,744
Closed -$323K
GLAD icon
14503
Gladstone Capital
GLAD
$452M
-63,790
Closed -$1.49M
DMRA
14504
CALL
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.9B
-4
Closed -$47
DMRA
14505
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.9B
-5,143
Closed -$61K
DMRA
14506
PUT
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.9B
-4
Closed -$47
GLV
14507
Clough Global Dividend & Income Fund
GLV
$78.8M
-16,353
Closed -$93.2K
CBIO
14508
CALL
Crescent Biopharma
CBIO
$610M
-494
Closed -$13.9K
CBIO
14509
PUT
Crescent Biopharma
CBIO
$610M
-178
Closed -$5.01K
GMAR icon
14510
FT Vest US Equity Moderate Buffer ETF March
GMAR
$397M
-19,351
Closed -$686K
GMF icon
14511
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$440M
-13,673
Closed -$1.52M
MRDN
14512
CALL
Meridian Holdings Inc
MRDN
$178M
-1,458
Closed -$43.2K
MRDN
14513
Meridian Holdings Inc
MRDN
$178M
-191
Closed -$5.66K
MRDN
14514
PUT
Meridian Holdings Inc
MRDN
$178M
-33
Closed -$988
GMOM icon
14515
Cambria Global Momentum ETF
GMOM
$72.4M
-18,258
Closed -$521K
GNE icon
14516
PUT
Genie Energy
GNE
$380M
-5,200
Closed -$76K
GNLN icon
14517
Greenlane Holdings
GNLN
$1.22M
-1
Closed -$29K
GNT
14518
GAMCO Natural Resources, Gold & Income Trust
GNT
$151M
-16,423
Closed -$90.2K
GOCO
14519
DELISTED
GoHealth
GOCO
-13,324
Closed -$130K
GOCT icon
14520
FT Vest US Equity Moderate Buffer ETF October
GOCT
$265M
-8,785
Closed -$300K
GORO icon
14521
PUT
Goldgroup Mining Inc.
GORO
$211M
-500
Closed -$187
GORV
14522
DELISTED
Lazydays
GORV
-24
Closed -$1.63K
GPIQ icon
14523
Goldman Sachs ETF Trust Goldman Sachs Nasdaq-100 Premium Income ETF
GPIQ
$5.41B
-13,810
Closed -$663K
GPOR icon
14524
Gulfport Energy Corp
GPOR
$3.01B
-1
Closed -$147
GQRE icon
14525
FlexShares Global Quality Real Estate Index Fund
GQRE
$423M
-7,655
Closed -$418K

Similar funds

Ken Griffin's Q3 2024 Portfolio in Review

As of Q3 2024, Ken Griffin held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Ken Griffin's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,611 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
  • Ken Griffin added most to NVIDIA in Q3 2024, an estimated $555M increase.
  • Ken Griffin's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
  • Ken Griffin fully exited Domino's in Q3 2024, selling an estimated $186M.
  • Ken Griffin's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
  • Ken Griffin opened 1,614 new positions and closed 1,611 in Q3 2024.
  • Ken Griffin's portfolio value rose 4.9% quarter-over-quarter to $518B.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.